| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.68B | 14.69B | 14.62B | 14.48B | 13.53B | 13.30B |
| Gross Profit | 4.50B | 4.74B | 4.22B | 4.32B | 4.35B | 4.50B |
| EBITDA | 1.59B | 1.76B | 1.36B | 1.10B | 1.17B | 1.36B |
| Net Income | 2.38B | 2.44B | 623.68M | 145.41M | 595.77M | 716.87M |
Balance Sheet | ||||||
| Total Assets | 34.38B | 37.31B | 32.47B | 33.75B | 36.30B | 29.76B |
| Cash, Cash Equivalents and Short-Term Investments | 4.04B | 4.73B | 2.46B | 1.99B | 6.06B | 4.59B |
| Total Debt | 4.73B | 4.29B | 4.90B | 6.31B | 5.80B | 742.65M |
| Total Liabilities | 11.21B | 12.04B | 11.03B | 12.29B | 16.04B | 9.62B |
| Stockholders Equity | 23.16B | 25.26B | 21.45B | 21.46B | 20.26B | 20.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.41B | 2.25B | -4.65B | -3.91B | -109.35M |
| Operating Cash Flow | 0.00 | 1.64B | 2.33B | 90.17M | 45.00M | 1.13B |
| Investing Cash Flow | 0.00 | 2.54B | 635.72M | -4.08B | -3.13B | -1.19B |
| Financing Cash Flow | 0.00 | -1.90B | -2.49B | 31.18M | 4.57B | -413.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥22.68B | -13.86 | ― | 1.87% | 4.26% | 27.55% | |
71 Outperform | ¥4.74T | 23.62 | 9.46% | 1.32% | 3.47% | 99.65% | |
71 Outperform | ¥1.39T | 21.75 | 11.19% | 1.46% | 5.16% | 1.57% | |
71 Outperform | ¥575.76B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
66 Neutral | ¥130.99B | 24.96 | ― | 1.08% | 4.45% | 11.13% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ¥22.35B | 23.77 | ― | 2.05% | 0.48% | 302.96% |